European Organisation for Research and Treatment of Cancer's point of view

Lancet. 2003 Aug 23;362(9384):663. doi: 10.1016/S0140-6736(03)14163-3.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Clinical Trials as Topic / legislation & jurisprudence*
  • Clinical Trials as Topic / standards
  • Europe
  • Humans
  • International Cooperation
  • Medical Oncology / legislation & jurisprudence*
  • Medical Oncology / organization & administration
  • Neoplasms / drug therapy
  • Organizations
  • Research / legislation & jurisprudence*
  • Research / standards

Substances

  • Antineoplastic Agents